Cart
sales@molnova.com
2’-Deoxy-N4-methylcytidine
CAS No. 22882-02-6
2’-Deoxy-N4-methylcytidine( —— )
Catalog No. M37908 CAS No. 22882-02-6
2’-Deoxy-N4-methylcytidine (N(3)-Methyl-2'-deoxycytidine) is a purine nucleoside analog with potential antitumor activity for the study of apoptosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 97 | Get Quote |
|
| 5MG | 148 | Get Quote |
|
| 10MG | 235 | Get Quote |
|
| 25MG | 441 | Get Quote |
|
| 50MG | 632 | Get Quote |
|
| 100MG | 860 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name2’-Deoxy-N4-methylcytidine
-
NoteResearch use only, not for human use.
-
Brief Description2’-Deoxy-N4-methylcytidine (N(3)-Methyl-2'-deoxycytidine) is a purine nucleoside analog with potential antitumor activity for the study of apoptosis.
-
Description2’-Deoxy-N4-methylcytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetAntibiotic
-
RecptorNucleoside Antimetabolite/Analog
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22882-02-6
-
Formula Weight241.24
-
Molecular FormulaC10H15N3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N([C@@H]2O[C@H](CO)[C@@H](O)C2)C=CC(NC)=N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.?
molnova catalog
related products
-
Cephalotin acid
Cephalotin acid is a beta-lactam antibiotic inhibits class C β-lactamase AmpC (Ki: 0.32 μM).
-
Cuprous iodide
Cuprous iodide (Iodocopper) is a antibiotic agent.
-
TBAJ-587
TBAJ-587 is a potent anti-tuberculosis agent. TBAJ-587 inhibits M.tb strain H37Rv growth with MIC90s of 0.006 and <0.02 μg/mL in MABA and LORA assay respectively. BAJ-587 has more potent activity against M. tuberculosis and better efficacy in animal models of TB.
